Epigallocatechin-3-gallate inhibits paclitaxel-induced apoptosis through the alteration of microRNA expression in human dermal papilla cells

Table 1 miRNAs showing > 3-fold expression change following treatment with EGCG in paclitaxel-exposed HDP cells

miRNA	Change relative to controls	Direction of regulation	chr.	miRNA	Change relative to controls	Direction of regulation	chr.
hsa-miR-3663-3p	293.53	Up	chr10	hsa-miR-500a-5p	105.14	Down	chrX
hsa-miR-1181	241.98	Up	chr19	hsa-miR-299-3p	102.72	Down	chr14
hsa-miR-3613-3p	188.92	Up	chr13	hsa-miR-140-5p	97.50	Down	chr16
hsa-miR-1281	177.19	Up	chr22	hsa-miR-193a-5p	73.05	Down	chr17
hsa-miR-1539	169.23	Up	chr18	hsa-miR-34a-3p	61.13	Down	chr1
hsa-miR-125a-3p	159.16	Up	chr19	hsa-miR-432-5p	60.05	Down	chr14
hsa-miR-4271	158.48	Up	chr3	hsa-miR-204-5p	56.88	Down	chr9
hsa-miR-550a-5p	156.32	Up	chr7	hsa-miR-485-3p	55.67	Down	chr14
hsa-miR-642b-3p	142.71	Up	chr19	hsa-miR-140-3p	55.23	Down	chr16
hsa-miR-23c	134.49	Up	chrX	hsa-miR-409-5p	54.21	Down	chr14
hsa-let-7f-1-3p	108.08	Up	chr9	hsa-miR-146a-5p	52.69	Down	chr5
hsa-miR-874	96.40	Up	chr5	hsa-miR-423-5p	50.69	Down	chr17
hsa-miR-33b-3p	88.74	Up	chr17	hsa-miR-17-3p	50.49	Down	chr13
hsa-miR-3180-5p	76.65	Up	chr16	hsa-miR-487a	47.24	Down	chr14
hsa-miR-150-3p	65.94	Up	chr19	hsa-miR-450a-5p	47.14	Down	chrX
hsa-miR-129-1-3p	64.80	Up	chr7	hsa-miR-138-2-3p	45.41	Down	chr16
hsa-miR-1249	63.67	Up	chr22	hsa-miR-128	44.19	Down	chr2
hsa-miR-3679-3p	60.74	Up	chr2	hsa-miR-28-5p	43.34	Down	chr3
hsa-miR-767-3p	34.07	Up	chrX	hsa-miR-431-5p	43.33	Down	chr14
hsa-miR-3656	3.60	Up	chr11	hsa-miR-146b-5p	43.22	Down	chr10
hsa-miR-221-5p	132.32	Down	chrX	hsa-miR-4317	38.84	Down	chr18
hsa-miR-374b	124.96	Down	chrX	hsa-miR-324-5p	38.47	Down	chr17
hsa-miR-590-5p	122.52	Down	chr7	hsa-miR-370	37.81	Down	chr14
hsa-miR-4306	116.09	Down	chr13	hsa-miR-16-2-3p	22.41	Down	chr3

ISSN: 2398-8460